Cronos Group Inc
(CRON)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRON | TBPH | SPRY | ||
| Company | Cronos Group Inc | Theravance Bio Ord | Ars Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.61 | 19.57 | 9.87 | ||
| High | 2.61 | 20.49 | 10.05 | ||
| Low | 2.61 | 19.00 | 9.70 | ||
| Latest | 2.61 | 20.48 | 10.03 | ||
| Change | -0.03 | +0.90 | +0.36 | ||
| % Change | -1.14% | +4.60% | +3.72% | ||
| Volume | 740 | 778,400 | 1,151,300 | ||
| 20-Day Average Volume | 1,529,505 | 363,705 | 1,733,465 | ||
| Previous Close | 2.56 | 19.58 | 9.67 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.62 | 19.91 | 10.63 | ||
| 20-Day Raw Stochastic | 55.81% | 79.01% | 12.11% | ||
| 20-Day Relative Strength | 50.21 | 58.92 | 46.86 | ||
| Weighted Alpha | +20.87 | +127.55 | -26.75 | ||
| Today's Opinion | 56% Buy | 100% Buy | 40% Sell | ||
| Previous Opinion | 24% Buy | 88% Buy | 56% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.18% since 01/30/26 | +8.13% since 01/30/26 | +0.40% since 01/30/26 | ||
| Low | 2.40 on 02/02/26 | 18.99 on 02/02/26 | 9.60 on 02/05/26 | ||
| High | 2.65 on 02/06/26 | 20.50 on 02/05/26 | 10.74 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | -1.86% since 01/06/26 | +11.91% since 01/06/26 | -10.04% since 01/06/26 | ||
| Low | 2.40 on 02/02/26 | 18.31 on 01/07/26 | 9.60 on 02/05/26 | ||
| High | 2.83 on 01/23/26 | 21.03 on 01/22/26 | 13.15 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | +6.88% since 11/06/25 | +37.73% since 11/06/25 | +22.39% since 11/06/25 | ||
| Low | 2.28 on 11/21/25 | 14.51 on 11/07/25 | 6.66 on 11/21/25 | ||
| High | 3.43 on 12/15/25 | 21.03 on 01/22/26 | 13.15 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | +25.71% since 08/06/25 | +83.18% since 08/06/25 | -44.22% since 08/06/25 | ||
| Low | 2.14 on 08/07/25 | 11.05 on 08/07/25 | 6.66 on 11/21/25 | ||
| High | 3.43 on 12/15/25 | 21.03 on 01/22/26 | 18.00 on 08/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,007,406 | 1,037,763 | 991,455 | ||
| Shares Outstanding, K | 381,593 | 50,672 | 98,849 | ||
| Annual Sales | 117,620,000 | 64,380,000 | 89,150,000 | ||
| Annual Net Income | 41,080,000 | -56,420,000 | 8,000,000 | ||
| Last Quarter Sales | 36,340,000 | 19,990,000 | 32,500,000 | ||
| Last Quarter Net Income | -6,570,000 | 3,620,000 | -51,150,000 | ||
| 60-Month Beta | 0.80 | 0.15 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 11/06/25 | 0.04 on 11/10/25 | -0.52 on 11/10/25 | ||
| Latest Earnings Date | 02/26/26 | 02/25/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.66 | 0.00 | ||